Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Germany
  4. Xetra
  5. PharmaSGP Holding SE
  6. Summary
    PSG   DE000A2P4LJ5

PHARMASGP HOLDING SE

(PSG)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Xetra
09/13/2021 09/14/2021 09/15/2021 09/16/2021 09/17/2021 Date
21.8(c) 22(c) 22(c) 21.4(c) 22(c) Last
1 619 2 264 5 568 7 009 2 962 Volume
+0.93% +0.92% 0.00% -2.73% +2.80% Change
More quotes
Estimated financial data (e)
Sales 2021 61,0 M 71,5 M 71,5 M
Net income 2021 10,5 M 12,3 M 12,3 M
Net Debt 2021 67,0 M 78,6 M 78,6 M
P/E ratio 2021 25,3x
Yield 2021 1,18%
Sales 2022 74,0 M 86,8 M 86,8 M
Net income 2022 12,0 M 14,1 M 14,1 M
Net Debt 2022 59,0 M 69,2 M 69,2 M
P/E ratio 2022 21,4x
Yield 2022 1,41%
Capitalization 264 M 310 M 310 M
EV / Sales 2021 5,43x
EV / Sales 2022 4,36x
Nbr of Employees 67
Free-Float 26,4%
More Financials
Company
PharmaSGP Holding SE is a Germany based company, which operates as a pharmaceutical company. The Company produces and develops non-chemical and over-the-counter drugs and other healthcare products. 
Sector
Other Specialty Retailers
Calendar
-
More about the company
Ratings of PharmaSGP Holding SE
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
-
More Ratings
All news about PHARMASGP HOLDING SE
09/16PHARMASGP : Product portfolio further expanded and internationalisation driven f..
EQ
09/16PRESS RELEASE : PharmaSGP: Product portfolio further expanded and internationali..
DJ
09/16PharmaSGP Holding SE Announces Financial Results for the First Half of 2021
CI
09/15PharmaSGP Holding SE raises forecast for FY 2021 following completion of acqu..
DJ
09/15PharmaSGP Holding SE Raises Financial Forecast for Fiscal Year 2021
CI
08/31PHARMASGP : GSK Closes Sale of Four OTC Brands to PharmaSGP
MT
08/31PHARMASGP : completes acquisition of OTC brand portfolio (Baldriparan(R), Formig..
EQ
08/31PRESS RELEASE : PharmaSGP Group completes acquisition of OTC brand portfolio (Ba..
DJ
08/27DGAP-RPT : PharmaSGP Holding SE: Release according to Article 111c of the AktG [..
DJ
07/12DGAP-PVR : PharmaSGP Holding SE: Release according to Article 40, Section 1 of t..
DJ
07/07DGAP-DD : PharmaSGP Holding SE english
DJ
06/28PHARMASGP HOLDING SE : Notification and public disclosure of transactions by per..
EQ
06/25PHARMASGP : successfully holds first AGM after IPO
EQ
06/25PRESS RELEASE : PharmaSGP successfully holds first AGM after IPO
DJ
06/20Certain Bearer Shares of PharmaSGP Holding SE are subject to a Lock-Up Agreem..
CI
More news
News in other languages on PHARMASGP HOLDING SE
09/16PHARMASGP : Produktportfolio in H1 2021 weiter ausgebaut und Internationalisieru..
09/16PHARMASGP : Produktportfolio in H1 2021 weiter ausgebaut und Internationalisieru..
09/15PharmaSGP Holding SE erhöht nach Vollzug des Erwerbs eines OTC-Markenportfoli..
09/15PharmaSGP Holding SE erhöht nach Vollzug des Erwerbs eines OTC-Markenportfoli..
09/15PharmaSGP Holding SE relève ses prévisions financières pour l'exercice 2021
More news
Chart PHARMASGP HOLDING SE
Duration : Period :
PharmaSGP Holding SE Technical Analysis Chart | PSG | DE000A2P4LJ5 | MarketScreener
Technical analysis trends PHARMASGP HOLDING SE
Short TermMid-TermLong Term
TrendsBearishBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 1
Last Close Price 22,00 €
Average target price 35,00 €
Spread / Average Target 59,1%
EPS Revisions
Managers and Directors
Natalie Weigand Chief Executive Officer
Michael Rudolf Chief Financial Officer
Clemens Fischer Chairman-Supervisory Board
Madlena Hohlefelder Deputy Chairman-Supervisory Board
Axel Rebien Member-Supervisory Board
Sector and Competitors
1st jan.Capi. (M$)
PHARMASGP HOLDING SE-17.69%302
ULTA BEAUTY, INC.33.14%20 782
E.L.F. BEAUTY, INC.19.97%1 566
SA SA INTERNATIONAL HOLDINGS LIMITED37.19%662
BEAUTY GARAGE INC.37.40%212
ENGLEWOOD LAB, INC.126.45%191